Cargando…

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019

Progression to severe disease is a difficult problem in treating coronavirus disease 2019 (COVID‐19). The purpose of this study is to explore changes in markers of severe disease in COVID‐19 patients. Sixty‐nine severe COVID‐19 patients were included. Patients with severe disease showed significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tao, Zhang, Jieying, Yang, Yuhui, Ma, Hong, Li, Zhenyu, Zhang, Jiaoyue, Cheng, Ji, Zhang, Xiaoyun, Zhao, Yanxia, Xia, Zihan, Zhang, Liling, Wu, Gang, Yi, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280589/ https://www.ncbi.nlm.nih.gov/pubmed/32428990 http://dx.doi.org/10.15252/emmm.202012421

Ejemplares similares

Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020)

Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)

A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level
por: Hambali, Nurfarah Lydia, et al.
Publicado: (2020)

Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients
por: Meng, Mei, et al.
Publicado: (2021)

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021)

Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis
por: Deimel, Lachlan Paul, et al.
Publicado: (2021)

Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019
por: Meng, Liye, et al.
Publicado: (2021)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
por: Li, Lili, et al.
Publicado: (2021)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6
por: Da, Ben L., et al.
Publicado: (2020)

Reply to letter to the editor: “Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019”
por: Erdoğan, Mehmet, et al.
Publicado: (2022)

Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker
por: Vazquez Guillamet, M. Cristina, et al.
Publicado: (2021)

Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients
por: Chen, Xiaohua, et al.
Publicado: (2021)

AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion
por: Ma, Yuxi, et al.
Publicado: (2019)

Bronchiectasis is one of the indicators of severe coronavirus disease 2019 pneumonia
por: Peng, Peng, et al.
Publicado: (2021)

Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19)
por: Laterre, Pierre Francois, et al.
Publicado: (2020)

Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy
por: Schwab, Kristin, et al.
Publicado: (2020)

Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019
por: Betts, Brian C., et al.
Publicado: (2020)

Meta-analysis of laboratory results in patients with severe coronavirus disease 2019
por: Huang, Yun, et al.
Publicado: (2021)

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019
por: Shang, You, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade
por: Bahmani, Mohaddeseh, et al.
Publicado: (2022)

Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

CT changes of severe coronavirus disease 2019 based on prognosis
por: Liang, Bin, et al.
Publicado: (2020)

Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools
por: Liu, Shanshan, et al.
Publicado: (2021)

Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury
por: Zhang, Dali, et al.
Publicado: (2020)

Spontaneous Pneumomediastinum: A Probable Unusual Complication of Coronavirus Disease 2019 (COVID-19) Pneumonia
por: Wang, Jing, et al.
Publicado: (2020)

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
por: Zhang, Fengqin, et al.
Publicado: (2022)

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
por: Liu, Bingwen, et al.
Publicado: (2020)

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019
por: Ma, Xiang, et al.
Publicado: (2021)

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
por: Santa Cruz, André, et al.
Publicado: (2021)

Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19
por: Luo, Kuan, et al.
Publicado: (2021)

Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019
por: Jain, Shashank, et al.
Publicado: (2020)

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019
por: Xiao, Lu-shan, et al.
Publicado: (2020)

Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010–2022
por: Zhou, Xianfeng, et al.
Publicado: (2023)

Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases
por: Zhang, Lin, et al.
Publicado: (2020)

Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update
por: Zhang, Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1smkfbf2ck4j6dm7b0eplmgu8r